WA
AXSM icon

WPG Advisers’s Axsome Therapeutics AXSM Stock Holding History

WPG Advisers’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Buy
76
+16
+27% +$3.47K 0.01% 570
2026
Q1 		$10.1K Sell
60
-18
-23% -$3.11K 0.01% 667
2025
Q4 		$14.2K Buy
78
+8
+11% +$1.12K 0.01% 599
2025
Q3 		$8.5K Buy
70
+1
+1% +$113 0.01% 744
2025
Q2 		$7.2K Buy
69
+8
+13% +$847 0.01% 756
2025
Q1 		$7.11K Buy
61
+21
+53% +$2.39K 0.01% 752
2024
Q4 		$3.38K Buy
+40
New +$3.68K ﹤0.01% 937

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WPG Advisers's AXSM Position: Q2 2026 in Review

WPG Advisers increased its Axsome Therapeutics (AXSM) stake by 27% in Q2 2026, buying an estimated $3.47K and bringing the position to 76 shares worth $18.6K. The position accounts for 0.01% of the portfolio, ranked #570.

WPG Advisers first reported a position in AXSM in Q4 2024 and has held it in 7 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • WPG Advisers held 76 shares of Axsome Therapeutics worth $18.6K as of Q2 2026.
  • WPG Advisers bought 16 Axsome Therapeutics shares in Q2 2026, an estimated $3.47K.
  • Axsome Therapeutics made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #570 holding.
  • WPG Advisers first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.